MH Consulting International in Perth, Western Australia | Pharmacy/chemists

MH Consulting International

Locality: Perth, Western Australia

Phone: +618414508212

Address: St Georges Terrace 6000 Perth, WA, Australia

Website: http://www.mhconsulting.in

Likes: 459

Add/Update information

Reviews

Tags

• Pharmacy/chemists
• Consultation agency
• Lawyer & law firm

25.01.2022 We are seeing a steady increase of medical cannabis use in PTSD patients as many are having good results in the treatment of various symtpms, such as relaxation..., sleep improvement, attenuation of hyperarousal and anxiety. In this review, Brazilian researchers examined the effects of natural D9-THC, dronabinol, and nabilone, administered alone and combined with CBD, on the extinction of aversive memories and anxiety. Their main findings: THC, dronabinol or nabilone could help with hyperarousal symptoms, insomnia, anxiety, and extinction deficits related to PTSD Low doses of THC potentiate fear memory extinction in healthy volunteers and reduce anxiety responses in anxious and PTSD patients without inducing a psychotic effect High doses of THC do not facilitate fear memory extinction and are related to clinically relevant anxiogenic and psychotic effects in healthy volunteers Human studies with an appropriate dose range of THC showed neither worsening of PTSD symptoms nor strengthening of aversive memories Few studies have investigated the effects of associating THC with CBD in varying dose ratios As with all cananbinoid protocols, getting the right dosage and ratio of the active constituents is the recepie for protocol efficacy and prevention of adverse events. Raymundi, A.M., da Silva, T.R., Sohn, J.M.B. et al. Effects of 9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies. BMC Psychiatry 20, 420 (2020). Doi: 10.1186/s12888-020-02813-8

25.01.2022 After Being Given 3 Days To Live, This Boy Is Now Perfectly Healthy Because His Mom Secretly Gave Him Cannabis!

25.01.2022 One of the reason why you its almost impossible to die from an overdose of cannabis : QUESTION Respiratory depression is associated with the overdose of opioi...ds or benzodiazepines. Is respiratory depression associated with an overdose of cannabinoids? Why or why not? ANSWER Respiratory depression is not associated with cannabinoid use because CB1 receptors are not located in the midbrain, the part of the brain responsible for respiratory drive.

24.01.2022 Tonight youre going to hear from Crystal Beattie and Grant Wideman, two veterans whos lives were changed by cannabis. In every state that has legalized #canna...bis there has been a reduction in opioid deaths. Its time we start to let our veterans medicate themselves with something that works. #txlege #SD19

24.01.2022 We just came across this resource by NPS MedicineWise (National Prescribing Service) designed to guide doctors in prescribing medical cannabis. Print this out and take with you to your appointment when asking your GP about using MC for your condition.

20.01.2022 "The doctor said to us cannabis doesnt belong in a baby and I said, cancer and chemotherapy dont belong in a baby." Ahurewa Rapira is one of the first babies in the country to be treated with medicinal cannabis. As Shilo Kino reports, its controversial.

19.01.2022 MCANZ Spokesperson Mark Crotty Interviews Cannasouth Plant Research New Zealand CEO Mark Lucas.

19.01.2022 QUESTION The pharmacological properties of cannabinol have been investigated. What have the studies shown? ANSWER Cannabinol (CBN) is the oxidative by-product o...f THC and appears after long storage. It is a weaker partial agonist at CB1 and CB2 as compared to THC. In in vitro studies, it has been found that cannabinol is anticonvulsant and anti-inflammatory, and stimulates bone formation. See more

19.01.2022 A great review of CBD’s mechanism of action and its potential applications in cancer therapy: CBD has demonstrated robust anti-proliferative and pro-apoptotic ...effects on a wide variety of cancer types both in cultured cancer cell lines and in mouse tumor models. The anti-tumor mechanisms vary based on tumor types, ranging from cell cycle arrest to autophagy, to cell death, or in combination. CBD can also inhibit tumor migration, invasion, and neo-vascularization, suggesting that CBD not only acts on tumor cells but can also affect the tumor microenvironment, for example by modulating infiltrating mesenchymal cells and immune cells. The dependency of CBD on the endocannabinoid receptors, CB1 and CB2, or the TRPV family of calcium channels, also varies, suggesting that CBD may have multiple cellular targets and/or different cellular targets in different tumors. Mechanistically, CBD seems to disrupt the cellular redox homeostasis and induce a drastic increase of ROS and ER stress, which could then exert the cell cycle arrest, autophagy, and cell death effects. For future studies, it is crucial to elucidate the interplays among different signaling transduction pathways, such as ROS, ER stress, and inflammation, in order to better understand how CBD treatment disrupts cellular homeostasis in both tumor cells as well as infiltrating cells, leading to cancer cell death and inhibition of tumor migration, invasion, metastasis, and angiogenesis. Seltzer ES, Watters AK, MacKenzie D Jr, Granat LM, Zhang D. Cannabidiol (CBD) as a Promising Anti-Cancer Drug. Cancers (Basel). 2020 Oct 30;12(11):E3203. doi: 10.3390/cancers12113203.

17.01.2022 We're ready! In a few days we'll be planting more than 80,000 medical-quality cannabis plants at Kkereng, north of Kaikura. Our regenerative winter crop wa...s a great success - and is now tilled-in to condition our soils and build up probiotic organic matter in the ground for better fertility, water retention and plant health. It's just another way we're working towards a sustainable future. Keep up to date as we share more planting and growing news shortly!

16.01.2022 Cannabis saved my daughter The tumors are gone! The tumors that St Jude discharged us over are GONE. There is still a spot that they can see, but it has no t...umor or mass. There is no change to the void left by her initial tumor resection, but thats expected. Her TBI is a forever thing. But her scans are clear, and her brain looks perfect. Cannabis is healing her from the inside out. She looks so good, that our scans have been pushed from every 3 months to every 6 months. And we no longer have to take an antibiotic on the weekends for her weakened immune system. One less pharmaceutical? Ill take it! This is all amazing news! We will be discussing an 8th surgery to remove the port in her chest, which will be a huge weight lifted. Last July we were starting hospice. I am blown away. None of this would be happening if it wasnt for Cannabis. Everynight we give her RSO, along with her behavior meds. This small squirt of plant medicine changed my world. It gave me faith in the universe again. I will always share the miracle of Cannabis. Life is so temporary, and every moment should be lived, not just survived. So start living my friends. Dont wait. Heal yourselves

15.01.2022 These Doctors Scientifically Explain How THC Relieves All Types of Pain!

12.01.2022 In the current state of prohibition, most medicinal Cannabis products are still yet to be listed as an approved item on the Australian Register of Therapeutic G...oods. Further to this, the stigma surrounding marijuana and the lack of medicinal Cannabis education for doctors can leave many patients burning questions unanswered ... Chronic pain is one of the most common conditions medicinal Cannabis is prescribed for. As patients and doctors become more aware of cannabinoid options, more are opting for the former rather than opioid therapy. Other conditions cannabinoid therapies are known to address include insomnia, anxiety, appetite loss, nausea, neuropathic pain, insomnia, PTSD, inflammatory bowel issues, inflammatory arthritis, palliative care, nausea and Multiple Sclerosis related muscle spasticity ... Patients are advised to seek specific advice from their doctors as there is a chance of Cannabis interfering with the metabolism of other medications. As Cannabis is metabolised in the liver, it may increase or decrease the metabolism of various other medications. There are very few pain medications that interact with Cannabis. Patients are always recommended to start cannabinoid therapy at very low doses and slowly increment and monitor over time. Other medications should not be immediately ceased, and your doctor should provide you with guidance if they can be slowly reduced over time ... medicinal Cannabis can support patients with anxiety and depression, given they have found their effective dosage. Cannabis can help alleviate pain, increase their psychical activity levels, sleep and improve their general well-being. With better quality of life, it may help with the patients mood and reduce anxiety ... There is also strong evidence in cannabis treating dependency on other drugs and acting as a reverse gateway drug. See more

11.01.2022 Thanks to News Talk 6PR 882 and Liam Bartlett for chatting with Associate Professor Daryl Efron from Murdoch Childrens Research Institute about his medicinal c...annabis trial for children with behavioural problems (some with Autism). Very promising results achieved and great news that Prof Efron has secured funding for a further RCT to hopefully further this proof. Listen here : https://www.6pr.com.au//medical-cannabis-may-reduce-sever/

10.01.2022 Few studies have measured how the breadth of common and commercially available Cannabis flower affects symptoms of depression in real-time. Using a mobile softw...are application (app.) for collecting the largest database of individual-level Cannabis administration sessions in the United States (US), it was found that Cannabis flower is an effective and fast acting anti-depressant medication. 9-tetrahydrocannabinol (THC) levels are the strongest independent predictors of symptom relief among the product characteristics, generally available to the US public, while cannabidiol (CBD) levels, instead, were generally unrelated to real-time changes in depressive symptom intensity levels. Among the most pressing epidemics faced by Western societies and future generations worldwide, depression is also a core feature of numerous other health conditions, including cancer, substance use disorders, anxiety disorders, schizophrenia, dementia, diabetes, cardiovascular disease, chronic pain and other physical disabilities ... Although the 2020 study extended the literature by incorporating a wider range of product characteristics than had been previously examined, it was still not able to include the full range (e.g. terpene profiles, vaping temperatures) and did not include non-flower Cannabis products. Other factors also not accounted for included Cannabis experience, whether or not respondents had a diagnosis of depression, or the concomitant use of medications other than Cannabis ... Given the significant costs to society from depression, the research herein offers hope for new avenues of treatment. Future research on Cannabis and depression is needed, directly comparing the short- and long-term treatment effectiveness and side effect severity of Cannabis use with conventional anti-depressant treatment, in conjunction with conventional treatment approaches and in the presence of clinically discouraged behaviours, such as alcohol consumption. See more

09.01.2022 Ahurewa Rapira is an anomaly according to the doctors at Auckland Starship Childrens Hospital. Almost 2-years-old Ahurewa has successfully used Cannabis alongs...ide Chemotherapy to help her recover from a very rare cancer (Acute Megakaryoblastic Leukemia) and it seems to have paid off! Ahurewa and her whanau have received her latest bone marrow biopsy and after 1 round of Chemotherapy her survival rate has gone up to 97%. One more round of chemotherapy treatment (just to make sure) and the family can take little Ahurewa home to the Manawatu. Ahu still has a long road ahead of her which will definitely include whole plant Cannabis medicines. For her whanau it is a whole new beginning. Acknowledgments to Dr Graham Gulbransen (Cannabis GP) and Erin Hudson (Medical Herbalist) for their professional support. Bravo to Ahurewa and her wonderful family, dad Brad Rapira, mum Rachael Potaka, grandma Tini Potaka and her big brother Hauiti. Auckland Patients Group is honoured to have had the opportunity to support this family through such a difficult time and thank them for sharing their journey for others to learn from. Pearl Schomburg See more

09.01.2022 Parents hail 10-month-olds response to cannabis oil treatment as amazing The parents of a baby girl who suffers severe seizures claim medicinal cannabis is s...aving her life. Three weeks ago, the 10-month-old was in ICU and doctors were preparing to put her into a coma and remove half her brain. Baby Luella has a rare type of epilepsy called West syndrome which causes her to suffer through hundreds of seizures a day. But when her parents turned to cannabis oil, they say the outcome was nothing short of miraculous. When youre in our shoes and none of the medicines are working youll do anything to stop the suffering of your child, absolutely anything, her mother Erin Oudshoorn told 7NEWS. Its amazing, she can track us around the room, she responds to her name. 7NEWS can reveal a secret state government farm has produced the first-ever cannabis crop for a new local industry that is being harvested and studied. It promises to make the treatment option more accessible and affordable for thousands of patients. Agriculture Minister Adam Marshall said its about creating the McDonalds of the medicinal cannabis world. Doctors are cautious and calling for more research into the safety and effectiveness of medicinal cannabis. For patients, the problem is that approved products can be expensive and difficult to source seeing many turn to the black market. Having a viable local industry in NSW is going to be crucial, particularly in a post-COVID-19 world, Marshall said. Luellas father David Oudshoorn says if theres an ability to source something locally that helps her its going to be far better for us. Its a remarkable change and a long road ahead but things are looking a little bit brighter, he said. https://7news.com.au//parents-hail-10-month-olds-response-

06.01.2022 In 1964 Raphael Mechoulam isolated THC from cannabis, and in 1980 he showed that CBD could be used for treating seizures. Despite this chemical progress, has wo...rk would go relatively unnoticed for an unusually long amount of time. Describing his experience in an interview with Discover Magazine, Mechoulam said: In the early 80s, we published a paper showing that cannabidiol [CBD] is a very good antiepileptic, and I thought it would be developed [as a drug], particularly since it shows no side effects. Nothing happened for 35 years, and then some parents, not companies, discovered cannabidiol helps their children with pediatric epilepsy. So, there was some pressure in the U.S., and social pressure in the U.S. works. Meanwhile, explaining how insulin came about, Mechoulam stated, Almost 100 years ago, when insulin was discovered, it was administered within six months; it became a drug within a year or two. From the words of a professional within the industry, the double standard cannabis faces as medicine is clear. There is a continual demand for more and more research on the substance, yet insulin is known to cause low blood sugar, which can result in seizures, fainting, or comas. Driving high may, or may not, negatively affect driving, but passing out from low blood sugar while driving certainly does. Still, millions of Americans rely on insulin daily. Cannabis is not a perfect substance, but it has studies showing that cannabis may help heal bone fractures, it may help mediate depression, and it may act as a neuroprotective substance. Additionally, work done by Mechoulam and his colleagues on the ECS, which he discovered, ended up with the discovery of anandamide, a fatty acid neurotransmitter. Anandamide is lower in the brains of people with PTSD, and cannabinoids have been found in research to be a potential novel treatment for the condition due to how closely THC mimics anandamide. Raphael Mechoulam recently celebrated his 89th birthday, but the father of cannabis research isnt done trying to uncover the secrets of marijuana. In 1964, Mechoulam discovered THC, the cannabinoid most famous for its intoxicating effect. The find in turn led to the discovery of the endocannabinoid system (ECS). The ECS likely plays a role in regulating immune function, but it also influences memory, mood, hormone regulation and more. Then, in 1980, Mechoulam showed that CBD, a cannabinoid swept up in the latest wellness trend, could treat seizures in epileptic patients. More than 30 years later, U.K.-based GW Pharmaceuticals took notice and developed Epidiolex, the first plant-based cannabis prescription drug, which was approved for sale in the U.S. in 2018. Now, Mechoulam says hes found a way to stabilize other cannabis compounds: cannabinoid acids, the molecules that come as precursors to cannabinoids in marijuana plants. These compounds may have even more therapeutic potential, due in part to their potency. CBDA, for example, is reportedly 1,000 times more potent than CBD when it comes to reducing nausea. It may be more therapeutic for other conditions as well. Mechoulam has partnered with the U.S.-based pharmaceutical IP company EPM to supply cannabinoid acid molecules for the development of new treatments. Trials in humans to treat psoriasis and inflammatory bowel disease are scheduled to begin next year. Discover recently interviewed Mechoulam about developing cannabinoid acids, treating addiction with cannabis derivatives, and what its like to devote your life to researching an often-stigmatized plant. This interview has been edited for clarity and length. Discover magazine: What exactly are cannabinoid acids, and how might they be useful to us? Raphael Mechoulam: The acids are the precursors of THC and CBD. The plant doesnt directly make THC and CBD, it makes the acids. They are precursors and these compounds, unfortunately, are not stable and therefore there has not been a lot of interest in them. We were glad to find out that it is a very potent compound, probably more active than CBD. It is a very good anti-anxiety agent, and we have found out that it lowers the side effects of cancer chemotherapy. It also has an anti-depressive effect and its a pretty potent anti-pain compound. Youve mentioned several of your discoveries largely went unnoticed when they were first published. Do you worry that could happen again with these acid-based cannabinoids? When we started work [in the early 60s], there was essentially no interest. Its kind of ridiculous. I asked for a grant from [National Institutes of Health] and they told me, Its not relevant. Nobody smokes marijuana in the U.S., people do it in Mexico. A year or two later, for some peculiar reason, a lot of people started smoking marijuana and then NIH, all of a sudden, became interested and they supported my work for almost 45 years. In the early 80s, we published a paper showing that cannabidiol [CBD] is a very good antiepileptic, and I thought it would be developed [as a drug], particularly since it shows no side effects. Nothing happened for 35 years, and then some parents, not companies, discovered cannabidiol helps their children with pediatric epilepsy. So, there was some pressure in the U.S., and social pressure in the U.S. works. The FDA approved a clinical trial, and the clinical trial said yes, its an excellent drug in certain types of epilepsy. And so [Epidiolex] has been approved. Now, the approval could have been made 35 years ago, and we could have helped thousands of children. So I hope that we wont have to wait 30 or 40 years for the other discoveries. Youve also pursued research into the cannabinoid-like compound anandamide, which might have therapeutic potential as well. What makes you excited about it? We are very much involved in addictions. This is, frankly, a new field, because until recently addiction was thought to be a kind of a psychological thing. We and many others have found that its not psychological, its an actual disease with compounds and reactions in the body. If a mouse is addicted to nicotine, for example, the body makes a particular anandamide-like compound which can work against addiction. It can prevent the addiction, or it can lower, very considerably, withdrawal effects. This particular compound lowers, or almost prevents, both nicotine and heroin withdrawal symptoms. So, here we have something quite practical, I hope. In the U.S. last year, 65,000 people died because of addiction they overdose themselves. In many cases, these are people who are willing to get rid of their addiction, but they couldnt. In many cases, this was due to the very strong withdrawal effects. And if there is a drug which essentially eliminates the withdrawal effects of opiates or nicotine, then I hope that it will be of wide use. But, you see, there is a really major need of clinical trials. Anandamide has never been given to a human as a drug. Almost 100 years ago, when insulin was discovered, it was administered within six months; it became a drug within a year or two. Here we have anandamide, a nontoxic compound which has never been administered, and so it has been sitting around for the last 25 years and nobody has been able to get the OK to give it to humans. Some of your work has focused on the immune system. Whats the connection between the endocannabinoid system and disease? From my point of view, our body tries to fight every single disease in most cases with the immune system. Its a very important system, but the immune system as we know it today doesnt address some of the diseases. So, the body has other ways to try to fight these diseases, and I believe that the endocannabinoid system is one of the major systems through which the body tries to fight disease. So, maybe in a decade or so, we should be speaking of not only the immune system but the endocannabinoid [system]. It may be an additional way the body attacks disease states. https://www.discovermagazine.com//the-father-of-cannabis-r

06.01.2022 Great news! The Ministry of Health - Manat Hauora has just granted Puro our licence to commercially cultivate and sell medical cannabis to pharmaceutical b...uyers. Were now able to germinate our low-THC crop in tunnel houses, and plant them at our Kkereng site when theyre ready. Kkereng is ready to grow 90,000 low-THC medical cannabis plants. This will be the largest medical cannabis crop in NZ a huge leap towards becoming a worldwide supplier of premium medical cannabis.

05.01.2022 Landon Riddle holding one of his Cannabis plants. Landon was diagnosed with an aggressive form of leukemia as a toddler and became the youngest patient in the U...nited States to receive a medical marijuana card." Full article: http://www.newsweek.com//medical-marijuana-pediatric-cance UNITED WE SPEAK UP FOR OUR KIDS #OGCannaMom #TeamLandon #CannaMoms #LandonsHealthHut #HelpingHands #Pioneer #CancerSucks #SoDoesTreatment #HeBeatCancer #NewsWeek #CNN #CBDforAll #thcforall #CantStopWontStop #morethan4 #rso #CannabisEducation #CannaMommy #CancerRebel #Pioneers #FuckCancer #WomenofCannabis #CannaKids

05.01.2022 I used to dream of being a normal mother. I would see other mums dropping their kids off at school, waving them goodbye and Id want to be them. Not the parent ...with a chronically ill child. For years, this scenario felt unattainable, but since my son Alfie Dingley became the first patient in the UK to receive a permanent cannabis licence, our family has been given hope. Theres a lot of fear around the word cannabis. But for Alfie and my family, it changed our lives. When he was five years old, my son was diagnosed with a rare form of epilepsy, called PCDH19, which caused up to 150 seizures a month. Alfie was just eight months old when we first took him to hospital following a terrifying series of seizures at our home one night in 2012. He was admitted for nearly four months and was having chronic seizures every 15 minutes to half an hour, which could last up to five minutes. It was incredibly frightening. He ended up being transferred on a life support machine into the Intensive Care Unit, before being taken to Great Ormond Street Hospital. Due to the severity of the seizures, it meant Alfie lost a lot of skills and was like a newborn again. Up until that point our son had been following the key developmental lines quite normally, such as sitting up and swallowing, but his condition took all that away. At that time, the trauma that we all went through especially Alfie was very distressing. He would be in hospital, pumped full of drugs and then would come home and act really aggressively. My son Alfie was five when he was diagnosed with a rare form of epilepsy (Picture: Hannah Deacon) He would lash out, scratch, kick and punch, due to the severe side effects of hundreds of seizures and the heavy drugs that were being used to stop the clusters. Even so, he would still get severe clusters every eight months until he was four, then they began to come every three weeks. By the time he was five, Alfie was having bouts of seizures every week. As a family, we were simply surviving and had no quality of life. My partner is over 6ft and plays rugby, and I knew that when Alfie got to that size I wouldnt be able to look after him anymore. I was worried about what our future might look like, especially when he got too big for me to handle. In 2017, after fundraising enough money, we travelled to the Netherlands for medical cannabis treatment, something that Id researched and learned could help lessen his seizures frequency and intensity. After six weeks of the treatment, administered as an oil under the tongue, Alfie went 17 days without any seizures. We continued to increase the dose of the medical cannabis and after five months, my son went 41 days with no seizures. Before we went to Holland, he was in hospital every week having hundreds of seizures. Now he was having fewer and needed much fewer pharmaceutical drugs. He was also learning new skills and his cognitive development notably improved. But after five months, we ran out of money so came home to fight our cause in the UK. What followed was several months of campaigning, petitioning the government to get Alfie a permanent medical cannabis licence. I worry about the impact this whole experience has had on my daughter, who is now five (Picture: Hannah Deacon) Eventually, in 2018, he was given one. Finally, Alfie was able to get a little bit of his quality of life back. He received his medication on the NHS and went 11 months with no seizures the longest amount of time since his diagnosis. It was amazing and felt like we were finally getting to really know our child. His quality of life hugely improved and we only saw benefits for him. It changed the whole family once he had his medicine. Although we have been lucky, so many other parents with chronically ill children are being failed. Access to medical cannabis is still difficult to obtain and families are not being supported the way they need and deserve to be. The cannabis medical treatment has given Alfie and our whole family our quality of life back (Picture: Hannah Deacon) I have spoken with parents of children with chronic illness who say they are not offered counselling or family support. Families with kids who have disabilities dont choose to be in this situation. It is forced on us and we are being consistently failed through a deficit of support, not enough social workers and a lack of respite care. This is why I keep campaigning for easier access to medicinal cannabis, because I think it should be available to people with epilepsy and all patients with chronic illness. Not only does it ease their pain, but it keeps them out of hospital thereby saving the NHS money. I dont want other parents to go through all that we have been through. I still feel a huge amount of grief about the fact that my child is ill. I dont know if he will live longer than me and, if he does, who will look after him when he gets older? I also worry about the effect all this has on my five-year-old daughter. She needs her mummy and Im conscious of the impact this could have on her as a child having a brother with epilepsy. But I manage this by remembering how far we have come with Alfie. Although we can still have bad days, its nothing like we experienced before his treatment. And I use this time to help others who are going through what we did. If Alfies legacy is that he helped me to support other people and that his name will be remembered because the law was changed in the UK, what a wonderful legacy that will be. Its turned a lot of grief into something positive. https://metro.co.uk//cannabis-treatment-saved-sons-life-1/

03.01.2022 Some of the results from the CAMS-18 survey of 1388 Australian medical cannabis (MC) users: Respondents reported using MC on 15.8 (11.2) days in the past 28, by... inhaled (71.4%) or oral (26.5%) routes and spending AUD$82.27 ($101.27) per week. Condition being treated with MC: 36.4% pain 32.8% mental health 9.2% sleep 5.2% neurological 3.8% cancer Few respondents (2.7%) had accessed legally prescribed medical cannabis, with the main perceived barriers being cost, disinterest from the medical profession and stigma regarding cannabis use. The symptoms managed with MC: 48% pain 44% anxiety 31.3% sleep problems The overwhelming majority of respondents reported symptom improvement following medical cannabis use. Attitudes to regulation of medical cannabis: 92% - medical cannabis should be part of routine healthcare in Australia 91.1% - medical cannabis should meet safety standards 91.0%t - he Australian regulatory framework for accessing medical cannabis did not work well 87.3% - the current model was difficult for patients to negotiate 78.3% - people should be able to buy and use medical cannabis without approval by a medical practitioner 70.7% - the government should subsidise the cost of medical cannabis 62.6%, the cost of licit medical cannabis was prohibitively expensive Lintzeris, N., Mills, L., Suraev, A. et al. Medical cannabis use in the Australian community following introduction of legal access: the 20182019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18). Harm Reduct J 17, 37 (2020). https://doi.org/10.1186/s12954-020-00377-0

01.01.2022 Just came across this great info-graphic showing THC and CBD formulations, conditions that may be effective for, and their expected level of psycho-activity :